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The biotechnologically relevant bacterium Corynebacterium glutamicum, currently used
for the million ton-scale production of amino acids for the food and feed industries, is
pigmented due to synthesis of the rare cyclic C50 carotenoid decaprenoxanthin and its glu-
cosides.The precursors of carotenoid biosynthesis, isopenthenyl pyrophosphate (IPP) and
its isomer dimethylallyl pyrophosphate, are synthesized in this organism via the methylery-
thritol phosphate (MEP) or non-mevalonate pathway. Terminal pathway engineering in
recombinant C. glutamicum permitted the production of various non-native C50 and C40
carotenoids. Here, the role of engineering isoprenoid precursor supply for lycopene pro-
duction by C. glutamicum was characterized. Overexpression of dxs encoding the enzyme
that catalyzes the first committed step of the MEP-pathway by chromosomal promoter
exchange in a prophage-cured, genome-reduced C. glutamicum strain improved lycopene
formation. Similarly, an increased IPP supply was achieved by chromosomal integration of
two artificial operons comprising MEP pathway genes under the control of a constitutive
promoter. Combined overexpression of dxs and the other six MEP pathways genes in
C. glutamicum strain LYC3-MEP was not synergistic with respect to improving lycopene
accumulation. Based on C. glutamicum strain LYC3-MEP, astaxanthin could be produced
in the milligrams per gram cell dry weight range when the endogenous genes crtE, crtB,
and crtI for conversion of geranylgeranyl pyrophosphate to lycopene were coexpressed
with the genes for lycopene cyclase and β-carotene hydroxylase from Pantoea ananatis
and carotene C(4) oxygenase from Brevundimonas aurantiaca.
Keywords: carotenoid production, genome-reduced Corynebacterium glutamicum, MEP pathway, synthetic
operons, astaxanthin
INTRODUCTION
Carotenoids are ubiquitous natural pigments with colors rang-
ing from yellow to red. They are composed of isoprene units and
belong to the family of terpenoids. These pigments do not only
play important and versatile roles in their biological hosts, but are
also suggested to have a beneficial effect on human health. Fur-
thermore, they are intensively applied for food and beverage col-
oration (Downham and Collins, 2000; Gassel et al., 2013). Hence,
carotenoids have received extensive considerable attention and
especially the interest for an efficient and environmental-friendly
production by microbial hosts is increasing (Lee and Schmidt-
Dannert, 2002; Das et al., 2007; Harada and Misawa, 2009; Cutzu
et al., 2013). In order to compete with already existing production
processes, such as chemical synthesis or extraction from organic
material, the large-scale production in microbial hosts requires
process as well as strain optimization. One of the most common
strategies for enhanced production is the efficient supply of pre-
cursor molecules as all carotenoids derive from the universal C5
precursor molecule IPP and its isomer DMAPP. IPP and DMAPP
can be synthesized via two independent pathways, the mevalonate
(MVA) and the 2-methylerythritol 4-phosphate (MEP) pathway
(Rodriguez-Concepcion and Boronat, 2002). The MVA pathway
starts from acetyl-CoA and operates mainly in eukaryotes (mam-
mals, fungi, in the cytoplasm of plant cells), archaea, and a limited
number of bacteria. The MEP pathway that starts from pyruvate
and glyceraldehyde 3-phosphate and proceeds via the eponymous
intermediate MEP was identified much later (Rohmer et al., 1993)
and is found in most bacteria as well as in plant plastids (Rohmer,
1999; Lange et al., 2000; Lee and Schmidt-Dannert, 2002). Both
pathways also differ regarding redox and energy requirements
(Steinbüchel, 2003). As the MEP pathway is present in several
pathogens such as Plasmodium falciparum and Mycobacterium
tuberculosis, but not in mammals, it is considered a drug target
(Jomaa et al., 1999; Testa and Brown, 2003).
The MEP pathway consists of nine reactions catalyzed by eight
enzymes (Figure 1) starting with the transfer of an acetaldehyde
group derived from pyruvate to GAP, forming 1-deoxy-d-xylulose
5-phosphate (DXP), in the reaction of DXP synthase Dxs (EC
2.2.1.7). The intermediate DXP is also the precursor for thi-
amine (vitamine B1) (Begley et al., 1999) and pyridoxol (vitamine
B6) (Hill et al., 1996) biosynthesis. Subsequently, DXP reducto-
isomerase Dxr (EC 1.1.1.267) converts DXP to MEP using NADPH
as cofactor. MEP is then converted to the cyclic diphosphate 2C-
methyl-d-erythritol-2,4-cyclodiphosphate (ME-cPP) by the three
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FIGURE 1 | Scheme of the MEP pathway (A) and of
decaprenoxanthin biosynthesis in C. glutamicum (B) with
heterologous astaxanthin biosynthesis. Gene names from
C. glutamicum (and gene IDs for MEP pathway genes) as well as gene
names from Pantoea ananatis and Brevundimonas aurantiaca (gray
boxes) are indicated. The structures of the endogenous C50 carotenoid
decaprenoxanthin and the heterologous C40 carotenoid astaxanthin are
given (GAP, glyceraldehyde 3-phosphate; DXP, 1-deoxy-d-xylulose
5-phosphate; MEP, 2-methylerythritol 4-phosphate; CDP-ME,
4-diphosphocytidyl-2-methylerythritol; CDP-MEP,
4-diphosphocytidyl-2-methylerythritol 2-phosphate; ME-cPP,
2-methylerythritol 2,4-cyclopyrophosphate; HMBPP,
4-hydroxy-3-methyl-but-2-enyl pyrophosphate; IPP, isopentenyl
pyrophosphate; DMAPP, dimethylallyl pyrophosphate).
enzymes IspD, IspE, and IspF (Gräwert et al., 2011). ME-cPP is
then converted to IPP and DMAPP by a reduction and elimina-
tion reaction catalyzed by the two iron–sulfur proteins IspG and
IspH (Rohdich et al., 2004). It is proposed that flavodoxin is an
essential redox partner for one of the enzymes (Adam et al., 2002;
Gräwert et al., 2004; Puan et al., 2005). IPP and DMAPP can be
synthesized independently by IspH (Gräwert et al., 2004). IPP and
DMAPP often do not occur in the same ratio as for example in
Escherichia coli IPP is synthesized in a 5:1 proportion to DMAPP
(Rohdich et al., 2002; Gräwert et al., 2004; Xiao et al., 2008). The
IPP:DMAPP isomerase Idi (EC 5.3.3.2) facilitates the isomeriza-
tion between IPP and DMAPP. In the case of microorganisms
using the MVA pathway produce/synthesize IPP exclusively, iso-
merases are essential enzymes, whereas in bacteria possessing the
MEP pathway idi is not essential for the survival of the cells (Hahn
et al., 1999; Julsing et al., 2007).
Corynebacterium glutamicum is a pigmented Gram-positive
bacterium with a long and safe history in the food and feed
sector as it is used for the fermentative production of amino
acids. Annually, about 2.6 million tons of l-glutamate and about
1.95 million tons of l-lysine are produced biotechnologically
worldwide (Ajinomoto, Food Products Business. Available from
http://www.ajinomoto.com/en/ir/pdf/Food-Oct2012.pdf and /Fe
ed-useAA-Oct2013.pdf, Cited 18 March 2014). Besides amino
acids, the diamines cadaverine and putrescine (Mimitsuka et al.,
2007; Schneider and Wendisch, 2010) and the alcohols ethanol
and isobutanol (Sakai et al., 2007; Blombach and Eikmanns,
2011), among others, can be produced from sugars by recombi-
nant C. glutamicum strains. Furthermore, access of C. glutamicum
to alternative feed stocks like glycerol from the biodiesel process
(Meiswinkel et al., 2013), pentoses from lignocellulosics (Gopinath
et al., 2011), amino sugars (Uhde et al., 2013; Matano et al., 2014),
starch (Seibold et al., 2006), and β-glucans (Tsuchidate et al., 2011)
has been engineered.
Recently, the potential of C. glutamicum for production
of carotenoids has been explored. C. glutamicum synthesizes
the cyclic C50 carotenoid decaprenoxanthin and its glucosides
(Figure 1). Its carotenogenic pathway and the respective genes
have been elucidated (Krubasik et al., 2001; Heider et al., 2012,
2014a) and overproduction of the C50 carotenoids decaprenox-
anthin, sarcinaxanthin, and C.p. 450 in the milligrams per gram
cell dry weight (DCW) range by C. glutamicum was achieved by
metabolic engineering of the terminal carotenoid pathway (Heider
et al., 2014a). Moreover, the heterologous production of the C40
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carotenoids β-carotene and zeaxanthin could be established (Hei-
der et al., 2014a) and hydroxylated carotenoids could be produced
either as aglycons or as di-glucosides (Heider et al., 2014a). Engi-
neering of C. glutamicum for the production of a sesquiterpene,
(+)-valencene, was possible as well (Frohwitter et al., 2014).
Based on its genome sequence, all genes of the MEP pathway
of C. glutamicum have been putatively assigned. However, nei-
ther have the respective genes or enzymes of the MEP pathway
been functionally analyzed nor has engineering for an increased
IPP supply been reported. The MEP pathway genes are distrib-
uted over the genome of C. glutamicum. The MEP pathway genes
dxs (cg2083), ispH (cg1164), and idi (cg2531) are monocistronic,
while dxr (cg2208), ispD (cg2945), ispE (cg1039), ispF (cg2944),
and ispG (cg2206) belong to operons. IspE is the third gene of the
operon cg1037-ksgA-ispE-cg1040-pdxK with genes for a putative
resuscitation-promoting factor (cg1037), putative dimethyladeno-
sine transferase KsgA, and putative pyridoxamine kinase PdxK.
IspD and ispF are encoded in the cg2946-ispDF operon with
cg2946, which codes for a CarD-like transcriptional regulator. Dxr
and ispG are organized in a transcriptional unit separated by an
uncharacterized gene (cg2207) putatively encoding a membrane-
embedded Zn-dependent protease. In bacteria, two bottlenecks in
the MEP pathway were proposed. On the one hand, DXP synthase,
which catalyzes the first reaction is claimed to be rate-limiting
(Sprenger et al., 1997; Xiang et al., 2007) and is essential in E. coli
(Sauret-Gueto et al., 2003) and Bacillus subtilis (Julsing et al., 2007)
and possibly further bacteria. On the other hand, overproduction
of Idi, which is not essential in bacteria possessing the MEP path-
way (Hahn et al., 1999; Julsing et al., 2007), improved carotenoid
production (Harker and Bramley, 1999; Kim and Keasling, 2001).
In this study, two synthetic operons (ispDFE and dxr-ispGH )
under control of the strong promoter Ptuf of the C. glutamicum
translation elongation factor EF-Tu gene were integrated into the
prophage-cured, genome-reduced C. glutamicum strain MB001
(Baumgart et al., 2013). Furthermore, dxs was overexpressed from
the chromosome by exchanging the endogenous promoter with
the Ptuf promoter. Finally, idi was overexpressed from an IPTG-
inducible plasmid. The genome-reduced strain overexpressing all
of the eight MEP pathway genes was then shown to be suitable
for production of lycopene and endogenous decaprenoxanthin as
well as for production of the non-native astaxanthin.
MATERIALS AND METHODS
BACTERIAL STRAINS, MEDIA AND GROWTH CONDITIONS
The strains and plasmids used in this work are listed in Table 1.
C. glutamicum ATCC13032 was used as wild type (WT), for
metabolic engineering the prophage-cured C. glutamicum MB001
(Baumgart et al., 2013) was used as platform strain. Precultiva-
tion of C. glutamicum strains was performed in LB medium or
LB with glucose. For cultivation in CGXII medium (Eggeling and
Reyes, 2005), precultivated cells were washed once with CGXII
medium without carbon source and inoculated to an initial OD600
of 1. Glucose was added as carbon and energy source to a concen-
tration of 100 mM. Standard cultivations of C. glutamicum were
performed at 30°C in a volume of 50 ml in 500 ml flasks with
two baffles shaking at 120 rpm. The OD600 was measured in dilu-
tions using a Shimadzu UV-1202 spectrophotometer (Duisburg,
Germany). Alternatively, cultivations were performed in 1 ml vol-
ume in microtiterplates at 1100 rpm at 30°C using Biolector®
micro fermentation system (m2p-labs GmbH, Baesweiler, Ger-
many). For cloning, E. coli DH5α was used as host and cultivated
in LB medium at 37°C. When appropriate, kanamycin or spectin-
omycin was added to concentrations of 25 and 100µg ml−1,
respectively. Gene expression was induced by adding 50µM and
1 mM IPTG, respectively, at inoculation of the main culture.
RECOMBINANT DNAWORK
Plasmids were constructed in E. coli DH5α from PCR-generated
fragments (KOD, Novagen, Darmstadt, Germany) and isolated
with the QIAprep spin miniprep kit (QIAGEN, Hilden, Germany).
Oligonucleotides used in this study were obtained from Eurofins
MWG Operon (Ebersberg, Germany) and are listed in Table 2.
Standard reactions like restriction, ligation, and PCR were per-
formed as described previously (Sambrook and Russell, 2001).
Besides the common ligation reaction, the Gibson assembly has
been applied for the construction of plasmids (Gibson et al., 2009).
If applicable, PCR products were purified using the PCR purifi-
cation kit or MinElute PCR purification kit (QIAGEN, Hilden,
Germany). For transformation of E. coli, the RbCl method was
used (Hanahan, 1983) and C. glutamicum was transformed via
electroporation (van der Rest et al., 1999) at 2.5 kV, 200Ω, and
25µF. All cloned DNA fragments were shown to be correct by
sequencing.
DELETION OF CAROTENOGENIC GENES IN C. GLUTAMICUM MB001
For deletion of the carotenogenic genes crtYe/f and crtEb, encod-
ing the C45/C50 carotenoid ε-cyclase and the lycopne elongase,
respectively, the suicide vector pK19mobsacB was used (Schäfer
et al., 1994). Genomic regions flanking the crtYEb cluster were
amplified from genomic DNA of C. glutamicum WT using primer
pairs crtY -A/crtY -B and crtEb-C/crtEb-D (Table 2), respectively.
The PCR products were purified and linked by crossover PCR
using the primer pair crtY -A/crtEb-D (Table 2). The purified
PCR product was cloned into pK19mobsacB resulting in the con-
struction of deletion vector pK19mobsacB-δcrtYEb (Table 1). The
targeted deletion of crtYEb via two-step homologous recombina-
tion as well as the selection for the first and second recombination
events were carried out as described previously (Eggeling and Bott,
2005). Deletion of crtYEb was verified by PCR analysis of the
constructed mutant using primer pair crtY-E/crtEb-F (Table 2).
CONSTRUCT DESIGN OF THE SYNTHETIC MEP OPERONS AND THEIR
INTEGRATION INTO THE GENOME OF C. GLUTAMICUM LYC3
The integration of the synthetic operons Op1 and Op2 was con-
ducted by using the suicide vector pK19mobsacB (Schäfer et al.,
1994). Op1 consists of the MEP-pathway genes ispD, ispF, and ispE
under the control of the constitutive Ptuf promoter. IspD and ispF
form a transcription unit and were amplified as such from genomic
DNA from C. glutamicum WT using the oligonucleotides 5 and
6. The primer pair 7/8 was used to amplify ispE from C. glutam-
icum WT, introducing an artificial ribosome binding site (RBS) in
front of the gene. The promoter region was amplified using the
oligonucleotides 3 and 4. In Op2 dxr, ispG and ispH were com-
bined, by amplification from the C. glutamicum WT genome using
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Table 1 | Strains and plasmids used in this study.
Strain, plasmid Relevant characteristics Source or reference
C. glutamicum STRAINS
WT ATCC 13032 Abe et al. (1967)
MB001 Prophage-cured ATCC 13032; in-frame deletion of prophages cgp1 (cg1507-cg1524), cgp2
(cg1746-cg1752), and cgp3 (cg1890-cg2071)
Baumgart et al.
(2013)
LYC3 crtYeYfEb deletion mutant of C. glutamicum MB001 This work
LYC3-Ptufdxs LYC3 derivative with dxs (cg2083) under control of the Ptuf promoter integrated into the
intergenic region of cg2083 and cg2084
This work
LYC3-Op1 LYC3 derivative with ispD (cg2945), ispF (cg2944), and ispE (cg1039) under control of the Ptuf
promoter integrated into the cgp2 cured region between cg1745 and cg1753
This work
LYC3-Op2 LYC3 derivative with dxr (cg2208), ispG (cg2206), and ispH (cg1164) under control of the Ptuf
promoter integrated into the cgp1 cured region between cg1506 and cg1525
This work
LYC3-Op1Op2 LYC3-Op2 derivative with ispD (cg2945), ispF (cg2944), and ispE (cg1039) under control of
the Ptuf promoter integrated into the cgp2 cured region between cg1745 and cg1753
This work
LYC3-MEP LYC3-Op1Op2 derivative with with dxs (cg2083) under control of the Ptuf promoter integrated
into the intergenic region of cg2083 and cg2084
This work
OTHER STRAINS
E. coli DH5α F− thi -1 endA1 hsdR17 (r− m−) supE44 ∆lacU169 (φ80lacZ∆M15) recA1 gyrA96 relA1 Hanahan (1983)
Pantoea ananatis ATCC 19321 Misawa et al. (1990)
Brevundimonas aurantiaca ATCC 15266 Abraham et al. (1999)
PLASMIDS
pK19mobsacB KmR; E. coli /C. glutamicum shuttle vector for construction of insertion and deletion mutants
in C. glutamicum (pK18 oriVEc sacB lacZα)
Schäfer et al. (1993)
pK19mobsacB-∆crtYEb pK19mobsacB with a crtYeYfEb deletion construct Heider et al. (2014a)
pK19mobsacB-Ptufdxs pK19mobsacB derivative with a tuf promoter region (200 bp upstream of the coding
sequence of the tuf gene(cg0587) construct for the promoter exchange of dxs
This work
pK19mobsacB-Op1 pK19mobsacB derivative containing the artificial operon ispDFE under the control of the Ptuf
promoter with an additional ribosome binding site in front of ispE for integration in the cgp2
cured region of C. glutamicum MB001
This work
pK19mobsacB-Op2 pK19mobsacB derivative containing the artificial operon dxr_ispGH under the control of the
Ptuf promoter with addition ribosome binding sites in front of ispG and ispH for integration in
the cgp2 cured region of C. glutamicum MB001
This work
pVWEx1 KmR; E. coli /C. glutamicum shuttle vector for regulated gene expression (Ptac, lacIq, pCG1
oriVCg)
Peters-Wendisch
et al. (2001)
pVWEx1-crtEBI pVWEx1 derivative for IPTG-inducible expression of crtE and the cluster crtBI from C.
glutamicum containing artificial ribosome binding sites each
Heider et al. (2014a)
pVWEx1-dxs pVWEx1 derivative for IPTG-inducible overexpression of dxs (cg2083) containing an artificial
ribosome binding site in front of the gene
This work
pVWEx1-idi pVWEx1 derivative for IPTG-inducible overexpression of idi (cg2531) containing an artificial
ribosome binding site in front of the gene
This work
pVWEx1-glpFKD pVWEx1 derivative for IPTG-inducible overexpression of glpF, glpK, and glpD from E. coli
MG1655
Rittmann et al.
(2008)
pEKEx3 SpecR; E. coli /C. glutamicum shuttle vector for regulated gene expression (Ptac, lacIq, pBL1
oriVCg)
Stansen et al. (2005)
(Continued)
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Table 1 | Continued
Strain, plasmid Relevant characteristics Source or reference
pEKEx3-crtEbY pEKEx3 derivative for IPTG-inducible expression of crtEb and crtY from C. glutamicum
containing artificial ribosome binding sites in front of each gene
Heider et al. (2014a)
pEKEx3-crtY pEKEx3 derivative for IPTG-inducible expression of crtY from P. ananatis containing an
artificial ribosome binding site in front of the gene
Heider et al. (2014a)
pEKEx3-crtYZ pEKEx3 derivative for IPTG-inducible expression of crtY and crtZ from P. ananatis containing
artificial ribosome binding sites in front of each gene
Heider et al. (2014a)
pEKEx3-crtYZW pEKEx3 derivative for IPTG-inducible expression of crtY and crtZ from P. ananatis and crtW of
Brevundimonas aurantiaca containing artificial ribosome binding sites in front of each gene
This work
pEKEx3-crtZWY pEKEx3 derivative for IPTG-inducible expression of crtY and crtZ from P. ananatis and crtW of
Brevundimonas aurantiaca containing artificial ribosome binding sites in front of each gene in
the order as depicted by the name
This work
pEKEx3-dxs pEKEx3 derivative for IPTG-inducible overexpression of dxs (cg2083) containing an artificial
ribosome binding site in front of the gene
This work
the primer pairs 15/16, 17/18, and 19/20, respectively. An artificial
RBS in front of ispG and ispH each was introduced by the oligonu-
cleotides 17 and 19, respectively. Also the genes of Op2 were put
under the control of the Ptuf promoter, amplified from genomic
DNA using the primers 13 and 14. Genomic regions flanking the
selected insertion region were amplified from genomic DNA of C.
glutamicum LYC3 using primer pairs 1/2 and 9/10 for integration
in the cgp2 cured region in the case of Op1, or 11/12 and 20/22 for
integration of Op2 in the cgp1 cured region (Table 2), respectively.
The purified PCR products were either linked by crossover PCR
or were directly combined together with the plasmid by Gibson
assembly (Gibson et al., 2009). The final assembly of the insert with
linearized pK19mobsacB led to the construction of the respective
integration vectors pK19mobsacB-Op1 and pK19mobsacB-Op2
(Table 1). The following integration of the operon by two-step
homologous recombination was performed according to the dele-
tion of genes. The integration of operon1 and 2 was verified by
PCR using the primers 29/30 and 31/32, respectively.
PROMOTER EXCHANGE OF THE dxs GENE IN C. GLUTAMICUM LYC3
The plasmid pK19mobsacB-Ptufdxs was constructed to replace the
native dxs promoter with the tuf promoter region from C. glutam-
icum WT. For this purpose, the upstream region of dxs (483 bp),
the 3′ part of dxs and the tuf promoter region [200 bp upstream of
the coding sequence of the tuf gene(cg0587)] were amplified from
chromosomal DNA of C. glutamicum LYC3 using the oligonu-
cleotide pairs 27/28, 23/24, and 25/26, respectively (Table 2).
By crossover PCR, the dxs 3′ fragment and the tuf promoter
region were fused with oligonucleotides 23/26. Afterward, the dxs
upstream region was fused to this 644 bp long fragment using
oligonucleotides 27/26. The final purified PCR product was cloned
into pK19mobsacB resulting in the vector pK19mobsacB-Ptufdxs
(Table 1). The following process for the promoter exchange by
two-step homologous recombination was performed as described
earlier for the deletion of genes. The promoter exchange was ver-
ified by PCR using the primers dxs_E and 33, and sequencing of
the PCR product.
OVEREXPRESSION OF CAROTENOGENIC GENES
Plasmids harboring a carotenogenic gene (general abbreviation
crt ), pEKEx3-crt or pVWEx1-crt allowed an IPTG-inducible over-
expression of crt. They were constructed on the basis of pEKEx3
(Stansen et al., 2005) or pVWEx1 (Peters-Wendisch et al., 2001),
respectively. Amplification of crt by polymerase chain reaction
(PCR) from genomic DNA of C. glutamicum WT, P. ananatis and
B. aurentiaca, which was prepared as described (Eikmanns et al.,
1995), was carried out using the respective primers (Table 2).
The amplification of the crt genes from was based on genomic
DNA as template. The amplified products were cloned into the
appropriately restricted pEKEx3 or pVWEx1 plasmid DNA.
EXTRACTION ANALYSIS OF CAROTENOIDS
To extract carotenoids from the C. glutamicum strains 15 ml
aliquots of the cell cultures were centrifuged at 10,000× g for
15 min and the pellets were washed with deionized H2O. The pig-
ments were extracted with 10 ml methanol:acetone mixture (7:3)
at 60°C for 30 min with thorough vortexing every 10 min. When
necessary, several extraction cycles were performed to remove all
visible colors from the cell pellet (Heider et al., 2012).
The extraction mixture was centrifuged 10,000× g for 15 min
and the supernatant was transferred to a new tube. The carotenoid
content in the extracts was quantified through absorbance at
470 nm by HPLC analysis (see below) and the concentrations were
calculated using a standard curve and appropriate dilutions. High
performance liquid chromatography (HPLC) analyses of the C.
glutamicum extracts were performed like described earlier (Heider
et al., 2014a) on an Agilent 1200 series HPLC system (Agilent Tech-
nologies Sales & Services GmbH & Co., KG, Waldbronn), includ-
ing a diode array detector (DAD) for UV/visible (Vis) spectrum
recording. For separation, a column system consisting of a precol-
umn (10 mm× 4 mm MultoHigh 100 RP18-5, CS Chromatogra-
phie Service GmbH, Langerwehe, Germany) and a main column
(ProntoSIL 200-5 C30, 250 mm× 4 mm, CS Chromatographie
Service GmbH, Langerwehe, Germany) was used. Quantification
of carotenoids was performed using the extracted wavelength
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Table 2 | Oligonucleotides used in this study.
Oligonucleotide Sequence (5′→3′)
crtEb-A AAAACCCGGGACTACCACTCCCGAGGTT
crtEb-B CCCATCCACTAAACTTAAACATAGAATTAGTCTTATTTTTTCCATCAT
crtEb-C TGTTTAAGTTTAGTGGATGGGACGATACTGCTAATAGCAATTCATCAGATATAA
crtEb-D AAAACCCGGGATGTGTGGGAGGCTTCGC
crtEb-E GGAGACTCAGCGTTTATGTC
crtEb-F AAAACAATGCGCAGCGCA
crtY -A AAAAGGATCCAGTCGGCTTCAGCATCC
crtY -B CCCATCCACTAAACTTAAACATGAAATATCGATGATAGGGATCAA
crtY -E TTGCACCTGCTGGATACGAA
crtY -F ATCGCTGCTGAAGGAGATGT
1 GCAGGTCGACTCTAGAGGATCCCCGTGCTTCGCATCGTCTATGTC
2 CATTCGCAGGGTAACGGCCAATAGTTGGGGGAATTTATAAGGATTTG
3 CAAATCCTTATAAATTCCCCCAACTATTGGCCGTTACCCTGCGAATG
4 GGGATTCGTGTAGACGACATTGTATGTCCTCCTGGACTTC
5 GAAGTCCAGGAGGACATACAATGTCGTCTACACGAATCCC
6 CGCCTTAGCGGTAATTTTCATCT GAAGGGCCTCCTTTCTTAAGCCTTCCACACCACTGC
7 GCAGTGGTGTGGAAGGCTTAAGAAAGGAGGCCCTTCAGATGAAAATTACCGCTAAGGCG
8 CTAATGGACGGTGAAGTATCATTTATGTTATGAAACAGTCAAAATGTGTGC
9 GCACACATTTTGACTGTTTCATAACATAAATGATACTTCACCGTCCATTAG
10 CCAGTGAATTCGAGCTCGGTACCCCGCCGTATGTAACAAGATTTG
11 GCAGGTCGACTCTAGAGGATCCCCCAGTGAAGGATCGGTGCG
12 CATTCGCAGGGTAACGGCCACCTATCTGCTGGCCGGTG
13 CACCGGCCAGCAGATAGGTGGCCGTTACCCTGCGAATG
14 GATCTTTTTAGTCACGACTCCCATTGTATGTCCTCCTGGACTTC
15 GAAGTCCAGGAGGACATACAATGGGAGTCGTGACTAAAAAGATC
16 CTAGAAAAGGAAGCCGCAT CTGAAGGGCCTCCTTTCTTACAAGTTGGTTGCCAACCG
17 CGGTTGGCAACCAACTTGTAAGAAAGGAGGCCCTTCAGATGCGGCTTCCTTTTCTAG
18 GCTGATAACAGGTGAGCTCAT CTGAAGGGCCTCCTTTCTTACTTGGTTACCTTCACTTCAG
19 CTGAAGTGAAGGTAACCAAGTAAGAAAGGAGGCCCTTCAGATGAGCTCACCTGTTATCAGC
20 TCTTACTACTTGCGCTAGGTACAGTTAATTCTTGTGGCGCAGC
21 GCTGCGCCACAAGAATTAACTGTACCTAGCGCAAGTAGTAAGA
22 CCAGTGAATTCGAGCTCGGTACCCCTGCTCATCCTTCAACAACGT
23 TGGCCGTTACCCTGCGAATG
24 TGTATGTCCTCCTGGACTTC
25 GAAGTCCAGGAGGACATACAATGGGAATTCTGAACAGTATTTC
26 CCAGTGAATTCGAGCTCGGTACCCCACACTATGCGTGGTATCG
27 GCAGGTCGACTCTAGAGGATCCCCCTGTCACTTTCCACACTGGTC
28 CATTCGCAGGGTAACGGCCATGGCGCGAGTCAGACAC
29 TCGCACCATCTACGACAACC
30 CTACGAAGCTGACGCCGAAG
31 GTGGTGCTCGAGAACATAAG
32 CGGTCACCCGTAACAATCAG
33 CAGGATCTTATGCACATAGGACTG
dxs_E CTGCGGCGTATTCAGAGTTC
Pa_crtY -fw CTGCAGGTCGACTCTAGAGGAAAGGAGGCCCTTCAGATGCAACCGCATTATGATCTG
Pa_crtY-rv1 CGGTACCCGGGGATCTTAACGATGAGTCGTCATAATGG
Pa_crtY-rv2 GGCATTCCAAATCCACAACATCTGAAGGGCCTCCTTTCTTAACGATGAGTCGTCATAATGG
Pa_crtZ-fw2 CCATTATGACGACTCATCGTTAAGAAAGGAGGCCCTTCAGATGTTGTGGATTTGGAATGCC
Pa_crtZ-rv CGGTACCCGGGGATCTTACTTCCCGGATGCGG
crtW-fw 2 CATCCGGGAAGTAAGATCCCCGAAAGGAGGCCCTTCAGATGACCGCCGCCGTCG
crtW-rv CGGTACCCGGGGATCTCAAGACTCGCCGCGCCAC
(Continued)
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Table 2 | Continued
Oligonucleotide Sequence (5′→3′)
A1 CTGCAGGTCGACTCTAGAGGAAAGGAGGCCCTTCAGATGACCGCCGCCGTCG
A2 CGGTACCCGGGGATCTCAAGACTCGCCGCGCCAC
A3 CAGATCATAATGCGGTTGCAT CTGAAGGGCCTCCTTTCTCAAGACTCGCCGCGCCAC
A4 GTGGCGCGGCGAGTCTTGAGAAAGGAGGCCCTTCAGATGCAACCGCATTATGATCTG
A6 CTGCAGGTCGACTCTAGAGGAAAGGAGGCCCTTCAGATGTTGTGGATTTGGAATGCC
A7 CGACGGCGGCGGTCAT CTGAAGGGCCTCCTTTCTTACTTCCCGGATGCGG
A8 CCGCATCCGGGAAGTAAGAAAGGAGGCCCTTCAGATGACCGCCGCCGTCG
pVWEx-fw CATCATAACGGTTCTGGC
pVWEx-rv ATCTTCTCTCATCCGCCA
M13 fw CACAGCGGGAGTGCCTATTGTTTTG
M13 rv CAGCGATGATCACTTCTGGCTC
Sequence in bold: artificial ribosome binding site; sequence underlined: restriction site; sequence in italics: linker sequence for hybridization.
chromatogram at 470 nm for decaprenoxanthin and carotenoids
with corresponding UV/Vis profiles as well as for lycopene and
corresponding carotenoids. Lycopene from tomato (Sigma, Stein-
heim, Germany), astaxanthin (Ehrenstorfer GmbH, Augsburg,
Germany), and β-carotene (Merck, Darmstadt, Germany) were
used as standards. The carotenoids were dissolved in chloroform
according to its solubility and diluted in methanol:acetone (7:3).
Due to the lack of appropriate standards decaprenoxanthin and
zeaxanthin quantification was calculated based on a β-carotene
standard and reported as β-carotene equivalents. The HPLC pro-
tocol comprised a gradient elution for 10 min and a mobile phase
composition of (A) methanol and (B) methanol/methyl tert-butyl
ether/ethyl acetate (5:4:1) starting from 10 to 100% eluent B fol-
lowed by 20 min of isocratic elution with 100% B. After that, the
eluent composition is set back to 10% B for 3 min. The injec-
tion volume was 50µl and the flow rate was kept constant at
1.4 ml/min.
DXS ACTIVITY ASSAY
The DXS activity of C. glutamicum crude extracts was determined
using an endpoint assay adopted from Xiang et al. (2007), which
is based on the measurement of the remaining pyruvate level in
the reaction mixture. The assays were carried out at 30°C in total
volume of 1 ml containing 50 mM Tris (pH 7.5), 60µM pyru-
vate, 60µM GAP, 10 mM dithiothreitol (DTT), 5 mM MgCl2, and
600µM TPP. Reactions were stopped after 5, 15, 30, and+60 min
of incubation by heat inactivation (5 min at 95°C). Subsequent the
leftover pyruvate was converted to lactate with lactate dehydroge-
nase and the concomitant consumption of NADH was determined
by fluorescence. Therefore, the reaction was allowed to proceed
for 60 min at room temperature. Then, 2.5 U ml−1 lactate dehy-
drogenase and 0.1 mM NADH was added to the reaction mixture
and incubated for 30 min at 37°C. The NADH diminution was
determined photometrically at 340 nm.
RESULTS
OVEREXPRESSION OF dxs INCREASED LYCOPENE YIELD
The first and often rate-limiting reaction in the MEP pathway is
the condensation of pyruvate and GAP to DXP catalyzed by Dxs
(Harker and Bramley, 1999; Kim and Keasling, 2001). To test if Dxs
is a bottleneck in carotenoid biosynthesis in C. glutamicum,dxs was
Table 3 | Influence of chromosomal promoter exchange of the
1-deoxy-d-xylulose 5-phosphate synthase gene dxs on Dxs
actitivities, growth rates, and lycopene production.
C. glutamicum
strain
Growth
rate (h−1)
final OD
(600 nm)
Dxs sp.
act. (mU
mg−1)
Lycopene
production
(mg g−1 DCW)
LYC3 0.45±0.01 27±1 9±1 0.04±0.01
LYC3-Ptuf dxs 0.44±0.02 24±2 16±1 0.08±0.01
LYC3(pEKEx3-dxs) 0.38±0.01 22±2 26±3 0.06±0.01
Cells were grown in glucose CGXII minimal medium for 24 h. Means and standard
deviations of three cultivations are reported.
overexpressed in C. glutamicum LYC3, a mutant derived from the
genome-reduced C. glutamicum strain MB001 (Baumgart et al.,
2013) that accumulates lycopene due to deletion of the lycopene
elongase and C45/C50 carotenoid ε-cyclase genes crtEb and crtYe/f.
To exchange the native dxs promoter by the strong constitutive
promoter of tuf (cg0587), which encodes for the elongation factor
EF-Tu (Fukui et al., 2011), the replacement vector pK19mobsacB-
Ptufdxs was constructed and C. glutamicum LYC3-Ptufdxs was
obtained. Dxs activities measured in crude extracts were about
twofold higher in C. glutamicum LYC3-Ptufdxs (16± 1 mU mg−1)
than in the control strain C. glutamicum LYC3 (Table 3). As
consequence of enhanced Dxs activity, lycopene production dou-
bled (0.08± 0.01 mg g−1 DCW as compared to 0.04± 0.01 mg g−1
DCW) (Table 3). Thus, increased Dxs activity improved lycopene
production by C. glutamicum. Increased specific Dxs activities
were also observed when a plasmid-borne copy of dxs was overex-
pressed from an IPTG-inducible promoter in LYC3, but lycopene
production was only slightly improved (Table 3). Hence, chromo-
somal overexpression proved better and was therefore chosen for
subsequent metabolic engineering of the MEP pathway.
OVERPRODUCTION OF ENZYMES CONVERTING DXP TO IPP USING TWO
SYNTHETIC OPERONS INTEGRATED INTO THE C. GLUTAMICUM
CHROMOSOME
For overproduction of the six MEP pathway enzymes catalyz-
ing the conversion of DXP to IPP, two synthetic operons were
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constructed and integrated into the chromosome of C. glutam-
icum LYC3. Operon 1 was constructed to drive expression of ispDF,
which are cotranscribed naturally, fused to ispE from Ptuf. The RBS
of the tuf gene was inserted upstream of ispD, while the endoge-
nous RBS of ispF and a perfect C. glutamicum RBS upstream of
ispE were used. To construct operon 2, dxr, ispG, and ispH were
fused for expression from Ptuf and perfect C. glutamicum RBS
were inserted upstream of ispG and ispH while the RBS of the tuf
gene was used upstream of dxr. Both operons were integrated by
homologous recombination into the chromosome of C. glutam-
icum LYC3, which lacks prophages cgp1 and cgp2. Operon 1 was
integrated into the chromosome of C. glutamicum LYC3 between
cg1506 and cg1525, i.e., at the position that harbors prophage cgp2
in the C. glutamicum WT, but which is absent from LYC3, and the
resulting strain was named LYC3-Op1. Similarly, C. glutamicum
LYC3-Op2 was obtained by integrating operon 2 into the chromo-
some of C. glutamicum LYC3 at the position (between cg1745 and
cg1753) that in C. glutamicum WT harbors prophage cgp1, but
which is absent from LYC3. The constructed C. glutamicum strain
LYC3-Op1Op2 contains both operons in the chromosome instead
of prophages cgp1 and cgp2. C. glutamicum LYC3-Op1 showed
slightly higher lycopene accumulation than C. glutamicum strains
LYC3 and LYC3-Op2. C. glutamicum LYC3-Op2 grew slower than
LYC3 and LYC3-Op1. C. glutamicum LYC3-Op1Op2 that harbors
both operons also grew slower, but accumulated almost threefold
more lycopene than LYC3. Thus, overexpression of MEP path-
way genes from two chromosomally integrated synthetic operons
improved lycopene production (Figure 2).
IMPROVED IPP SUPPLY BY CHROMOSOME-BASED ENHANCEMENT OF
MEP PATHWAY GENE EXPRESSION
To combine chromosome-based overexpression of the genes nec-
essary for conversion of DXP to IPP with overproduction of Dxs,
the first enzyme of the MEP pathway, the endogenous promoter of
chromosomal dxs was exchanged by Ptuf in C. glutamicum LYC3-
Op1Op2 and the resulting strain was named C. glutamicum LYC3-
MEP. Surprisingly, LYC3-MEP showed slower growth on solid as
well as in liquid medium. Poor growth in liquid glucose medium
was accompanied by little lycopene production, although LYC3-
MEP colonies appeared well pigmented on plates. Since the central
carbon metabolites pyruvate and GAP are the immediate precur-
sors of the MEP pathway, it was tested if lycopene production by
C. glutamicum LYC3-MEP was affected by the carbon source. To
this end, pyruvate and glycerol were tested as carbon sources. Since
glycerol is no carbon source for C. glutamicum WT, glpFKD from
E. coli encoding the enzyme for conversion of glycerol to GAP
were expressed from plasmid pVWEx1-glpFKD (Rittmann et al.,
2008) in C. glutamicum LYC3-MEP. Growth by C. glutamicum
LYC3-MEP(pVWEx1-glpFKD) on glycerol, glycerol+ glucose, or
glycerol+ pyruvate was still impaired, but about twofold more
lycopene (around 0.07± 0.01 mg g−1 DCW) accumulated than
with glucose as sole carbon source (Figure 3).
Since IspH synthesizes both IPP and DMAPP, but typically
not in equimolar amounts (Rohdich et al., 2002; Gräwert et al.,
2004; Xiao et al., 2008), it is possible that unbalanced biosyn-
thesis of IPP and DMAPP in C. glutamicum LYC3-MEP impairs
FIGURE 2 | Lycopene production by C. gluamicum LYC3 and derived
strains expressing the synthetic ispDFE operon (LYC3-Op1), the
synthetic dxr-ispGH operon (LYC3-Op2) or both operons
(LYC3-Op1Op2) for overproduction of MEP pathway enzymes. Cells
were grown in glucose CGXII minimal medium. Means and standard
deviations of three cultivations are shown.
FIGURE 3 | Lyopene production by C. gluamicum LYC3-MEP(pVWEx1-
glpFKD) on glycerol as sole and combined carbon source. LYC3-MEP
(pVWEx1-glpFKD) cells were grown in CGXII minimal medium with 200 mM
glycerol (Gly), 100 mM glycerol+100 mM pyruvate (Gly/Pyr), or 100 mM
glycerol+50 mM glucose (Gly/Glu), respectively. Expression of glpFKD was
induced by 50µM IPTG. As reference, lycopene production of the strains
LYC3 and LYC3-MEP grown in CGXII minimal medium with 100 mM glucose
(Glu) is given. Means and standard deviations of three cultivations are
reported.
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growth and carotenogenesis. To test this hypothesis, isopentenyl
pyrophosphate isomerase Idi was overproduced. Indeed, C. glu-
tamicum LYC3-MEP(pVWEx1-idi)(pEKEx3) produced twofold
more lycopene (0.08± 0.02 mg g−1 DCW) than C. glutamicum
strains LYC3, LYC3-MEP, and the empty vector control strain,
but still showed impaired growth (Table 4). Thus, a lycopene
producing C. glutamicum strain with improved IPP supply over-
expressing all MEP pathway genes and idi could be constructed.
However, lycopene production by this strain (Table 4) was com-
parable to that by C. glutamicum strains LYC3-Ptufdxs (Table 3)
and LYC3-Op1Op2 (Figure 2) indicating that the positive effects
did not act synergistically. This was also observed when the strains
were grown in LB medium supplemented with 100 mM glucose;
however, they grew faster (data not shown). Taken together, C. glu-
tamicum strains with improved IPP and DMAPP supply showed
higher lycopene production than the respective parental strains.
APPLICATION OF C. GLUTAMICUM WITH IMPROVED IPP SUPPLY FOR
PRODUCTION OF DECAPRENOXANTHIN AND ASTAXANTHIN
To test if C. glutamicum LYC3-MEP overexpressing idi is
suitable for production of the endogenous C50 carotenoid
decaprenoxanthin, this strain was transformed with plasmid
pEKEx3-crtEbY. Expression of lycopene elongase gene crtEb
and of carotenoid ε-cyclase gene crtYe/f from this plas-
mid complements the lycopene producing C. glutamicum
LYC3-MEP, which carries chromosomal crtEb and crtYe/f deletions
allowing for decaprenoxanthin biosynthesis. The resulting
strain LYC3-MEP(pVWEX1-idi)(pEKEx3-crtEbY ) overproduces
Table 4 | Growth rates and lycopene production by prophage-cured,
MEP pathway genes overexpressing C. glutamicum strain LYC3-MEP.
C. glutamicum strain Growth
rate (h−1)
final OD
(600 nm)
Lycopene
production
(mg g−1 DCW)
LYC3 0.45±0.01 27±1 0.04±0.01
LYC3-MEP 0.16±0.01 23±1 0.03±0.01
LYC3-MEP(pVWEx1)(pEKEx3) 0.15±0.00 23±2 0.04±0.02
LYC3-MEP(pVWEx1-idi )(pEKEx3) 0.13±0.01 20±1 0.08±0.02
Cells were grown in glucose CGXII minimal medium and plasmid carrying
strains were induced with 50µM IPTG. Means and standard deviations of three
cultivations are shown.
all enzymes of endogenous carotenogenesis except crtE, crtB,
and crtI (Figure 1). Although it grew slowly, LYC3-MEP
(pVWEX1-idi)(pEKEx3-crtEbY ) produced 0.35± 0.02 mg g−1
DCW (Table 5) and, thus, is a genome-reduced strain with
improved IPP supply suitable for the overproduction of the
endogenous C50 carotenoid decaprenoxanthin.
C. glutamicum has previously been engineered for the produc-
tion of the non-native C40 carotenoids β-carotene and zeaxan-
thin (Heider et al., 2014a). When crtY Pa (PANA_4160) encoding
lycopene cyclase from Pantoea ananatis was expressed, β-carotene
accumulated. Additional expression of crtZ Pa (PANA_4163),
which encodes β-carotene hydroxylase, resulted in partial con-
version of β-carotene to zeaxanthin (Heider et al., 2014a).
To enable astaxanthin production, crtW Ba encoding carotene
C(4) oxygenase from Brevundimonas aurantiaca, which oxi-
dizes zeaxanthin to yield astaxanthin, was expressed in addi-
tion to crtY Pa and crtZ Pa. The resulting plasmid pEKEx3-
crtZWY was used to transform LYC3-MEP(pVWEX1-idi). C. glu-
tamicum LYC3-MEP(pVWEX1-idi)(pEKEx3-crtZWY ) produced
0.14± 0.01 mg g−1 DCW astaxanthin and neither β-carotene nor
zeaxanthin accumulated (Table 5). Thus, to the best of our knowl-
edge, this is the documentation of astaxanthin production by
recombinant C. glutamicum. Although levels were low, LYC3-
MEP(pVWEX1-idi)(pEKEx3-crtZWY ) produced astaxanthin as
only carotenoid.
Based on our previous findings that overexpression of the
genes crtE, crtB, and crtI (Figure 1) strongly increased lycopene
production (Heider et al., 2012), as well as decaprenoxan-
thin production (Heider et al., 2014a); these genes were over-
expressed from plasmid pVWEx3-crtEBI. The resulting strain
C. glutamicum LYC3-MEP(pVWEx3-crtEBI )(pEKEx3-crtZWY )
produced 2.1± 1.3 mg g−1 DCW β-carotene and 1.2± 0.2 mg g−1
DCW zeaxanthin (Table 5), but also ninefold more astax-
anthin (1.2± 0.5 mg g−1 DCW) than LYC3-MEP(pVWEx1-
idi)(pEKEx3-crtZWY ). Thus, it was shown that astaxanthin can
be produced by recombinant C. glutamicum in the milligrams per
gram DCW range.
DISCUSSION
Recently, C. glutamicum has been engineered for production
of diverse lycopene-derived carotenoids (Heider et al., 2014a)
and of a sesquiterpene (Frohwitter et al., 2014). There is an
increasing demand for efficient, low-cost, and natural production
of terpenoids (Zhu et al., 2014) as they have many applications,
Table 5 | Astaxanthin and decaprenoxanthin production by recombinant C. glutamicum strains with improved IPP supply.
C. glutamicum strain Production (mg g−1 DCW)
Decaprenoxanthin β-Carotene Zeaxanthin Astaxanthin
LYC3-MEP(pVWEx1)(pEKEx3) <0.01 <0.01 <0.01 <0.01
LYC3-MEP(pVWEx1-idi )(pEKEx3-crtEbY ) 0.4±0.1 <0.01 <0.01 <0.01
LYC3-MEP(pVWEx1-idi )(pEKEx3-crtZWY ) <0.01 <0.01 <0.01 0.1±0.0
LYC3-MEP(pVWEx1-crtEBI)(pEKEx3-crtZWY ) <0.01 2.1±1.3 1.2±0.2 1.2±0.5
Cells were grown in glucose CGXII minimal medium with 50µM IPTG. Means and standard deviations of three cultivations are reported.
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e.g., in the medicinal and nutraceutical industries or as fuels
(Martin et al., 2003; Ajikumar et al., 2010; Peralta-Yahya et al.,
2011). Besides terminal terpenoid pathway engineering, an effi-
cient supply of the prenyl pyrophosphate precursors is important
(Heider et al., 2014b). It could be shown here that MEP pathway
engineering to improve IPP supply in C. glutamicum improved
lycopene production. However, as observed in similar studies of
MEP pathway engineering in other bacteria individual bottle-
necks may be overcome, but the individual beneficial effects do
not necessarily add up (Kim and Keasling, 2001; Martin et al.,
2003; Rodriguez-Villalon et al., 2008). Overexpressing the ini-
tial MEP pathway gene, dxs improved lycopene production by
C. glutamicum (see Figure 1) and by other bacteria (Harker and
Bramley, 1999; Matthews and Wurtzel, 2000). However, optimal
overexpression levels need to be established since, e.g., chromo-
somal overexpression proved better than overexpression from a
multy-copy plasmid (Yuan et al., 2006). Similarly, when dxs was
overexpressed in C. glutamicum by exchanging the native pro-
moter of dxs with the strong constitutive tuf promoter more
lycopene accumulated than when plasmid-borne dxs overexpres-
sion, which led to higher Dxs activities, was tested (Table 3). The
complex interplay of MEP pathway enzymes is also reflected by
the fact that overexpression of dxr, ispG, and ispH in LYC3-Op2
only improved lycopene accumulation when combined with over-
expression of ispDF and ispE (Op1) (Figure 2). Although lycopene
titers obtained with C. glutamicum LYC3-Op1Op2 were compa-
rable to the dxs overexpressing strain LYC3-Ptufdxs (Figure 2 and
Table 3), their combination in strain LYC3-MEP was not syn-
ergistic and even perturbed growth. This may be explained by
accumulation of inhibitory MEP pathway intermediates as shown
for B. subtilis (Sivy et al., 2011) and E. coli (Martin et al., 2003;
Zou et al., 2013), from an excessive drain of central metabolic
intermediates (Kim and Keasling, 2001) and/or from an imbal-
ance between IPP and DMAPP (Kajiwara et al., 1997). In C.
glutamicum, improved lycopene production as consequence of
overexpression of IPP isomerase gene idi was observed in LYC3-
MEP (Table 4). However, lycopene production by LYC3-MEP
overexpressing idi was not higher than by LYC3-Ptufdxs or by
LYC3-Op1Op2. Moreover, when dxs was overexpressed in the WT-
derived strain ∆crtEb lycopene production increased from about
0.04 to about 0.12 mg g−1 DCW, but combined overexpression of
dxs and idi did not further increase lycopene production (data not
shown). Thus, the perturbed growth may not only be due to an
imbalance between IPP and DMAPP.
It remains to be shown if combinatorial approaches to optimize
multiple gene expression levels (Zelcbuch et al., 2013; Nowroozi
et al., 2014) would improve the IPP precursor supply in C. glu-
tamicum. Fine-tuning of gene expression in recombinant C. glu-
tamicum by varying promoters (Holátko et al., 2009; van Ooyen
et al., 2011; Schneider et al., 2012), RBSs (Schneider et al., 2012),
translational start codons (Schneider et al., 2012), or translational
stop codons (Jensen and Wendisch, 2013) improved production of
amino acids and diamines. In addition,overexpression of heterolo-
gous instead of endogenous genes may be beneficial, e.g., as shown
for improving isoprene production by E. coli via overexpression of
two MEP pathway genes dxs and dxr from B. subtilis (Zhao et al.,
2011) or by combining overexpression of xylA from Xanthomonas
campestris with endogenous xylB to accelerate xylose utilization
of C. glutamicum (Meiswinkel et al., 2013).
Besides fine-tuning of MEP pathway gene overexpression,
growth, and terpenoid production by recombinant C. glutamicum
with increased IPP supply could be improved by metabolic pull,
i.e., by overexpression of genes of the downstream terpenoid path-
way (Table 5). Similarly, amorphadiene synthase overexpression
prevented accumulation of inhibitory isoprenoid pathway inter-
mediates in E. coli (Martin et al., 2003). Overcoming the toxicity
of accumulating IPP and DMAPP was successfully used as screen-
ing method for the identification of genes that are involved in
isoprenoid biosynthesis (Withers et al., 2007). Accumulation of
the MEP pathway intermediate ME-cPP inhibits growth and iso-
prenoid production by recombinant E. coli. To abolish its accumu-
lation overexproducing the two enzymes downstream of ME-cPP
(ispG and ispH ) needed to be combined with overexpressing an
operon for iron–sulfur cluster assembly since both IspG and IspH
are containing iron–sulfur clusters (Zou et al., 2013).
To the best of our knowledge, production of astaxanthin by
recombinant C. glutamicum was shown here for the first time.
Astaxanthin is the third most important carotenoid after β-
carotene and lutein and its global market amounted to about 230
million US$ in 2010 (BBC Research, 2011). The economically most
significant application of astaxanthin is its use as feed additive
in aquaculture industry (Lorenz and Cysewski, 2000; Higuera-
Ciapara et al., 2006; Schmidt et al., 2011), but it also exhibits high
potential as a nutraceutical and as an approved ingredient for
cosmetics due to its remarkably high antioxidative activity (Miki,
1991; Schmidt et al., 2011). Astaxanthin is mainly produced by
marine bacteria and microalgae, but only the green freshwater
microalga Haematococcus pluvialis and the red yeasts Xanthophyl-
lomyces dendrohous/Phaffia rhodozyma are established as hosts for
commercial production (Bhosale and Bernstein, 2005; Rodriguez-
Saiz et al., 2010). Algae-based production of astaxanthin is still
more costly than chemical synthesis (Jackson et al., 2008), but
markets more and more demand naturally produced carotenoids.
The astaxanthin titers by recombinant C. glutamicum reported
here are in the milligrams per gram DCW range and, thus, they
are comparable to yields described for P. rhodozyma (ranging from
0.16 to 6.6 mg g−1 DCW (Cruz and Parajo, 1998; Jacobson et al.,
1999). The highest product titer of 9.7 mg g−1 DCW is reported
for a P. rhodozyma strain improved by metabolic engineering and
classical mutagenesis (Gassel et al., 2013), while the highest titer in
a recombinant bacterium, i.e., E. coli strain was 5.8 mg g−1 DCW
astaxanthin (Zelcbuch et al., 2013). Thus, the astaxanthin titers
reported for C. glutamicum are comparable and it is conceiv-
able that they may be improved further by combining metabolic
engineering with classical mutagenesis as in P. rhodozyma (Gas-
sel et al., 2013), by combinatorial approaches to gene expression
(Zelcbuch et al., 2013), or by high-cell density cultivation since
biomass concentrations of up to 95 g DCW/l have been reported
for C. glutamicum (Riesenberg and Guthke, 1999).
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